What the buyer needs
AI summaryThe Richard P. Feynman Center for Innovation offers a technology licensing opportunity for SignalGen, a generative AI platform that predicts the optimal signal peptide for a specific protein. The buyer seeks a partner to license this technology, which utilizes a protein language model and a natural-language AI agent to evaluate the protein, target cellular location, and source organism to enhance protein expression. The technology holds a technology readiness level of 3, with a pending U.S. patent (S-195368). Interested parties can direct inquiries to [email protected], though the provided text omits specific bidder eligibility criteria, submission deadlines, evaluation methods, contract terms, and budget details.
Scope of work
- Licensing of SignalGen technology and generative AI platform
- Access to protein language model trained on proteins and associated signal peptides
- Natural-language interface AI agent for signal peptide prediction workflows
Incumbent and award research
No incumbent history found for this requirement. The notice does not cite a current contract, and no earlier award from this buying office matches it.
Market context
Awards in the same category (Research and Development in Biotechnology (except Nanobiotechnology)). This is not this requirement's award history.
Recent similar awards: Department of Energy, NAICS 541714
| Vendor and award | Value | Ends |
|---|---|---|
| THE LELAND STANFORD JUNIOR UNIVERSITY89303024PFE000117 · FOR STANFORD UNIVERSITY, RENEW MEMBERSHIP IN THE STANFORD CENTER FOR CARBON STORAGE (SCCS) | $100.0K | Jun 30, 2025 |
| THE LELAND STANFORD JUNIOR UNIVERSITY89303022CFE000006 · MEMBERSHIP TO THE STANFORD CENTER FOR CARBON STORAGE (SCCS) | $200.0K | May 31, 2024 |
Source: USAspending.gov federal award data (U.S. federal public data). A contract is called the incumbent only when the notice or its documents cite it by number.